Chloroquine-resistant Plasmodium vivax, Brazilian Amazon [8]

Emerging Infectious Diseases

Volumn 13, Issue 7, 2007, Pages 1125-1126

  De Santana Filho, Franklin Simoes ^a   Arcanjo, Ana Ruth De Lima ^a   Chehuan, Yonne Melo ^a   Costa, Monica Regina ^a   Martinez Espinosa, Flor Ernestina ^a,b   Vieira, Jose Luis ^c   Barbosa, Maria Das Graças Vale ^a,d   Alecrim, Wilson Duarte ^a,e   Alecrim, Maria Das Graças Costa ^a,d,e  

^a Foundation for Tropical Medicine of Amazonas (FMTAM)   (Brazil)

^b Foundation for Research Support of Amazonas   (Brazil)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^d Amazonas State University Dental School   (Brazil)

^e UNIVERSIDADE NILTON LINS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DEETHYLCHLOROQUINE; MEFLOQUINE; PRIMAQUINE;

BLOOD SMEAR; BRAZIL; DRUG EFFICACY; IN VIVO STUDY; LETTER; MALARIA; NONHUMAN; PLASMODIUM VIVAX; PUBLIC HEALTH;

EID: 34447258220     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1307.061386     Document Type: Letter

References (10)

1. Marlar-Than, Myat-Phone-Kyaw, Aye-Yu-Soe, Khaing-Khaing-Gyi, Ma- Sabai, Myint-Oo. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans R Soc Trop Med Hyg. 1995;89:307-8.
2. Congpuong K, Na-Bangchang K, Thimasarn K, Tasanor U, Wernsdorfer WH. Sensitivity of Plasmodium vivax to chloroquine in Sa Kaeo Province, Thailand. Acta Trop. 2002;83:117-21.
3. Hamedi Y, Nateghpour M, Tan-ariya P, Tiensuwan M, Silachamroon U, Looareesuwan S. Plasmodium vivax malaria in southeast Iran in 1999-2001: establishing the response to chloroquine in vitro and in vivo. Southeast Asian J Trop Med Public Health. 2002;33:512-8.
4. Baird JK, Wiady I, Fryauff DJ, Sutanihardja MA, Leksana B, Widjaya H, et al. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg. 1997;56:627-31.
5. Phillips EJ, Keystone JS, Kain KC. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis. 1996;23:1171-3.
6. Ruebush TK II, Zegarra J., Cairo EM, Andersen M, Green DR., Pillai W, et al. Chloroquine-resistant Plasmodium vivax malaria in Peru. Am J Trop Med Hyg. 2003;69:548-52.
7. Alecrim MGC. Estudo clínico, resistência e polimorfismo parasitário na malária pelo Plasmodium vivax, Manaus - AM. Brasília: UNB, 2000. PhD Thesis, Faculdade de Medicina, Núcleo de Medicina Tropical, Universidade de Brasília, 2000.
8. Baird JK, Leksana B, Masbar S, Fryauff DJ, Sutanihardja MA, Suradi FS, et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood levels. Am J Trop Med Hyg. 1997;56:621-6.
9. Pan-American Health Organization. Generic protocol for antimalarial drug-efficacy studies in the Américas. Efficacy of chloroquine for the treatment of Plasmodium vivax malaria. 2004. [cited 2007 May 15]. Available from http://www.paho.org/english/AD/DPC/CD/mal-antimalarials.htm
10. Yonemitsu K, Koreeda A, Kibayashi K, Ng'walali P, Mbonde M, Kitinya J, et al. HPLC analysis of anti-malaria agent, chloroquine in blood and tissue from forensic autopsy cases in Tanzania. Leg Med (Tokyo). 2005;7:113-6.